Brett A. Giffin - 26 Feb 2022 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role
Chief Commercial Officer
Signature
/s/ John Sprague, Attorney-in-fact
Issuer symbol
TTOO
Transactions as of
26 Feb 2022
Net transactions value
$0
Form type
4
Filing time
30 Mar 2022, 16:05:31 UTC
Previous filing
23 Feb 2022
Next filing
11 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTOO Restricted Stock Units Award $0 +500,000 $0.000000 500,000 26 Feb 2022 Common Stock 500,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 The restricted stock units vest in three equal annual installments on November 8, 2022, November 8, 2023, and October 1, 2024.